Welcome to Prodrome
Our products are scientifically designed for medical professionals. You must register for an account to place an order.
If you are a medical professional please register for an account to order our products to carry in your office or to get your medical access code that can be used by your patients to purchase directly from us.
If you are not a medical professional please use the access code provided by your doctor to register for an account to access our store.
Thank you for your interest in Prodrome!
Already registered? Login to order now.
ProdromeScan Blood Test
A revolution in health optimization.
Based on Dr. Dayan Goodenowe’s invention in 1999 and over 15 years of clinical research. Measures hundreds of molecules and key biochemical systems critical for optimal health and longevity.
Our supplements are scientifically designed to correct deficiencies in key molecules identified by our ProdromeScan blood test.
ProdromeNeuro and ProdromeGlia Plasmalogen Oil
Plasmalogen molecules are necessary for optimal health and longevity. The research evidence is now overwhelming with numerous physicians using our plasmalogen supplement with patients. ProdromeNeuro Plasmalogen Oil is funded by the Alzheimer’s Association (PCTR-16-381605, Part the CloudTM ).
ProdromeGTA is specifically formulated to mimic activity that compensates for a gastrointestinal tract acid (GTA) deficiency. This deficiency is identified by our ProdromeScan blood test. GTAs are molecules that originate in the gut. Low levels are linked to increased risk of colorectal cancer and pancreatic cancer.
Dayan Goodenowe, PhD
FOUNDER AND CEO
Inventor. Biochemist. Neuroscientist. Synthetic organic chemist. International speaker. Entrepreneur.
Dr. Goodenowe invented an advanced mass spectrometry technology platform in 1999 that has been used to analyze thousands of human samples from around the world and continues to be the most advanced technology of its kind today. Using this technology, he established collaborations with world-renowned international researchers and physicians in dementia, Alzheimer’s, Parkinson’s, multiple sclerosis, colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, bipolar disorder, schizophrenia, and several other diseases. Dr. Goodenowe is an expert on the biochemical basis of disease. His passion is targeted optimization of human biochemistry for longevity and vitality.
20 years of research.
Dr. Goodenowe’s technology platform:
Invented in 1999.
Over 50 scientific publications.
Over 25 diseases studied.
Over 30 academic collaborations worldwide.
Over 12,000 human blood and tissue samples analyzed.
New research on asthma, lung health, and plasmalogens April 7, 2020 Research on asthma, lung function, and plasmalogens demonstrates how important plasmalogens are for many